SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

RPG Life Sciences - Quaterly Results

18 Oct 2025 Evaluate
A fair growth of 5.50% in the revenue at Rs. 1816.80 millions was reported in the September 2025 quarter as compared to Rs. 1722.10 millions during year-ago period.The Net Profit of the company reported a remarkable increase of 777.38% to Rs. 368.50  millions  from Rs. 42.00 millions in previous same quarter.The company reported a degrowth in operating Profit to 435.70 millions from 478.70 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 1816.80 1722.10 5.50 3506.00 3376.30 3.84 6534.30 5820.50 12.26
Other Income 45.40 19.40 134.02 97.70 43.10 126.68 126.80 72.10 75.87
PBIDT 435.70 478.70 -8.98 842.70 893.10 -5.64 1723.30 1353.60 27.31
Interest 1.20 1.70 -29.41 2.50 3.20 -21.88 6.20 4.50 37.78
PBDT 546.70 204.00 167.99 952.40 616.90 54.38 2543.10 1349.10 88.50
Depreciation 52.20 53.10 -1.69 103.60 106.00 -2.26 214.30 170.70 25.54
PBT 494.50 150.90 227.70 848.80 510.90 66.14 2328.80 1178.40 97.62
TAX 126.00 108.90 15.70 217.40 201.30 8.00 496.40 301.80 64.48
Deferred Tax 10.40 1.10 845.45 11.10 -1.60 -793.75 -0.50 -23.60 -97.88
PAT 368.50 42.00 777.38 631.40 309.60 103.94 1832.40 876.60 109.03
Equity 132.30 132.30 0.00 132.30 132.30 0.00 132.30 132.30 0.00
PBIDTM(%) 23.98 27.80 -13.73 24.04 26.45 -9.13 26.37 23.26 13.40

RPG Life Sciences Share Price

1893.15 14.10 (0.75%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..
Register Now to get our Free Newsletter & much more!

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×